# Synthon Pharmaceuticals, Inc – FDA Inspection, Apr 3, 2009

Source: https://www.keypedia.com/records/fda_inspections/synthon-pharmaceuticals-inc/f5283d1b-96aa-443d-a84c-c362f817c0b5
Source feed: FDA_Inspections

> FDA inspection 603514 of Synthon Pharmaceuticals, Inc, April 03, 2009. Classification: Voluntary Action Indicated (VAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 603514
- Company Name: Synthon Pharmaceuticals, Inc
- Inspection Date: 2009-04-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 782270 - 2012-05-18](https://www.keypedia.com/records/fda_inspections/synthon-pharmaceuticals-inc/e84d1666-82c0-4b8b-8e08-0c3bdf600134)
- FDA Inspection 659289 - 2010-03-30
- FDA Inspection 658237 - 2010-03-30

Company: https://www.keypedia.com/companies/synthon-pharmaceuticals-inc/cf016655-8e6a-4594-a42e-98107c959c23

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c